Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-30 Purchase |
2021-12-02 5:08 pm |
VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director |
12,500 | $1.0159 | $12,699 | 62,500 (Direct) |
View |
| 2021-08-25 Purchase |
2021-08-26 5:04 pm |
VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director |
12,500 | $1.6 | $20,000 | 50,000 (Direct) |
View |
| 2021-08-16 Sale |
2021-08-18 7:19 pm |
VYNE Therapeutics Inc. | VYNE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
250,000 | $1.74 | $435,000 | 4,935,057 (Indirect) |
View |
| 2021-08-13 Sale |
2021-08-17 4:46 pm |
VYNE Therapeutics Inc. | VYNE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
250,000 | $1.84 | $460,000 | 5,185,057 (Indirect) |
View |
| 2021-08-12 Sale |
2021-08-16 6:24 pm |
VYNE Therapeutics Inc. | VYNE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
338,897 | $2.23 | $755,740 | 5,435,057 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-30 Tax Withholding |
2022-10-04 5:00 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
10,683 | $0.223 | 1,040,270 (Direct) |
View |
| 2022-08-10 Option Award |
2022-08-12 5:12 pm |
N/A 2032-08-10 |
VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2022-08-10 Option Award |
2022-08-12 5:11 pm |
N/A 2032-08-10 |
VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2022-08-10 Option Award |
2022-08-12 5:11 pm |
N/A 2032-08-10 |
VYNE Therapeutics Inc. | VYNE | Bruno Anthony D Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2022-08-10 Option Award |
2022-08-12 5:10 pm |
N/A 2032-08-10 |
VYNE Therapeutics Inc. | VYNE | Basta Steven L Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2022-08-10 Option Award |
2022-08-12 5:10 pm |
N/A 2032-08-10 |
VYNE Therapeutics Inc. | VYNE | BARBARI SHARON Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2022-06-30 Tax Withholding |
2022-07-05 5:01 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO |
354 | $0.389 | 173,712 (Direct) |
View |
| 2022-06-30 Tax Withholding |
2022-07-05 5:01 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
1,719 | $0.389 | 223,691 (Direct) |
View |
| 2022-06-30 Tax Withholding |
2022-07-05 5:00 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,813 | $0.389 | 232,770 (Direct) |
View |
| 2022-06-30 Tax Withholding |
2022-07-05 5:00 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
10,683 | $0.389 | 1,050,953 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 4:36 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO |
12,510 | $0.3463 | 174,066 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 4:35 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
11,887 | $0.3463 | 1,061,636 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-04 5:10 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO |
773 | $0.65 | 161,556 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-04 5:09 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
3,469 | $0.65 | 225,410 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-04 5:09 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
3,630 | $0.65 | 234,583 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-04 5:08 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
23,186 | $0.65 | 1,049,749 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-18 5:10 pm |
N/A 2032-03-17 |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO |
75,000 | $0 | 237,329 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-18 5:10 pm |
N/A 2032-03-17 |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
75,000 | $0 | 303,879 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-18 5:09 pm |
N/A 2032-03-17 |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
75,000 | $0 | 313,213 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-18 5:09 pm |
N/A 2032-03-17 |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
624,605 | $0 | 1,385,238 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-04 4:40 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO |
206 | $1.02 | 87,329 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-04 4:40 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
1,250 | $1.02 | 153,879 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-04 4:40 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,484 | $1.02 | 163,213 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-04 4:39 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
6,887 | $1.02 | 760,633 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 5:08 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO |
4,187 | $0.8755 | 87,535 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 5:07 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
4,705 | $0.8755 | 767,520 (Direct) |
View |
| 2021-09-30 Tax Withholding |
2021-10-01 5:12 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO |
206 | $1.39 | 83,348 (Direct) |
View |
| 2021-09-30 Tax Withholding |
2021-10-01 5:12 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
1,480 | $1.39 | 155,129 (Direct) |
View |
| 2021-09-30 Tax Withholding |
2021-10-01 5:11 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,484 | $1.39 | 164,697 (Direct) |
View |
| 2021-09-30 Tax Withholding |
2021-10-01 5:10 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
13,096 | $1.39 | 762,815 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-03 5:35 pm |
N/A 2031-09-02 |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO |
121,719 | $0 | 144,414 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-03 5:34 pm |
N/A 2031-09-02 |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
121,719 | $0 | 217,469 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-03 5:34 pm |
N/A 2031-09-02 |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
121,719 | $0 | 227,041 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-03 5:33 pm |
N/A 2031-09-02 |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
640,625 | $0 | 1,096,224 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-20 5:06 pm |
N/A 2031-07-19 |
VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director |
20,500 | $0 | 20,500 (Direct) |
View |